PI
IOVA icon

PEAK6 Investments’s Iovance Biotherapeutics IOVA Stock Holding History

PEAK6 Investments’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$201K – 3753
2024
Q2 		$201K Sell
25,000
-7,500
-23% -$80.4K ﹤0.01% 2747
2024
Q1 		$482K Buy
+32,500
New +$378K ﹤0.01% 2469
2022
Q1 		– Sell
-16,800
Closed -$321K – 5564
2021
Q4 		$321K Hold
16,800
– – ﹤0.01% 3603
2021
Q3 		$414K Hold
16,800
– – ﹤0.01% 3405
2021
Q2 		$437K Hold
16,800
– – ﹤0.01% 3346
2021
Q1 		$532K Buy
+16,800
New +$696K ﹤0.01% 3138

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

PEAK6 Investments's IOVA Position: Q2 2021 in Review

PEAK6 Investments sold out of Iovance Biotherapeutics (IOVA) in Q2 2021, closing a stake of 11,393 shares — an estimated $296K sold.

PEAK6 Investments first reported a position in IOVA in Q1 2021 and held it in 1 quarter. The position peaked at $361K in Q1 2021. 233 funds tracked by Wall St. Rank hold IOVA as of Q2 2021.

  • PEAK6 Investments reported no remaining Iovance Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • PEAK6 Investments sold 11,393 Iovance Biotherapeutics shares in Q2 2021, an estimated $296K.
  • PEAK6 Investments first reported a position in Iovance Biotherapeutics in Q1 2021 and held it in 1 quarter.
  • PEAK6 Investments's Iovance Biotherapeutics position peaked at $361K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.